Evidence map›Paper›PMID 37214982›Full record

ArticlemedRxiv : the preprint server for health sciences2023

A digital health intervention to support patients with chronic pain during prescription opioid tapering: a pilot randomised controlled trial.

Ali Gholamrezaei, Michael R Magee, Amy G McNeilage, Leah Dwyer, Alison Sim, Manuela L Ferreira, Beth D Darnall, Timothy Brake, Arun Aggarwal, Meredith Craigie and 3 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ali GholamrezaeiSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Michael R MageeSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Amy G McNeilageSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Leah DwyerConsumer Advisory Group, Painaustralia, Deakin, Victoria, Australia.
Alison SimSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Manuela L FerreiraSydney Musculoskeletal Health, Kolling Institute, School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Beth D DarnallDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California, USA.
Timothy BrakePain Management Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Arun AggarwalPain Management Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Meredith CraigiePain Management Unit, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, South Australia, Australia.
Irina HollingtonPain Management Unit, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, South Australia, Australia.
Paul GlareSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Claire E Ashton-JamesSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
The University of Sydney · AUQueen Elizabeth Hospital · AUStanford University · US

Funding

Research and Mentoring in Innovative Patient Oriented Pain and Opioid ScienceK24DA053564 · NIDA · STANFORD UNIVERSITY · PI Beth Denise Darnall · 2021 to 2026
$1.0M
NIDA NIH HHS K24 DA053564
6 · The paper itself

Abstract

Introduction: Recent changes in opioid prescribing guidelines have led to an increasing number of patients with chronic pain being recommended to taper. However, opioid tapering can be challenging, and many patients require support. Objectives: We evaluated the feasibility, acceptability, and potential efficacy of a co-designed psycho-educational video and SMS text messaging intervention to support patients with chronic pain during prescription opioid tapering. Methods: A pilot randomised controlled trial was conducted. In addition to their usual care, participants in the intervention group received a psycho-educational video and 28 days of text messages (two SMS/day). The control group received usual care. The feasibility, acceptability, and potential efficacy of the intervention were evaluated. The primary outcome was opioid tapering self-efficacy. Secondary outcomes were pain intensity and interference, anxiety and depression symptom severity, pain catastrophising, and pain self-efficacy. Results: Of 28 randomised participants, 26 completed the study (13 in each group). Text message delivery was 99.2% successful. Most participants rated the messages as useful, supportive, encouraging, and engaging, 78.5% would recommend the intervention to others, and 64% desired a longer intervention period. Tapering self-efficacy (Cohen's Conclusions: It is feasible, acceptable, and potentially efficacious to support patients with chronic pain during prescription opioid tapering with a psycho-educational video and SMS text messaging intervention. A definitive trial has been initiated to test a 12-week intervention.

Indexed as

digital healthmHealthmobile healthOpioidpaintapering

Identifiers

PMID37214982
PMCPMC10197816
OpenAlexW4376127867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.